BIBV 308 SE solution
Sponsors
Boehringer Ingelheim
Conditions
Healthy
Phase 1
Relative Bioavailability and Tolerability of Two New Different Extended Release Capsules of BIBV 308 SE, Versus a Solution of BIBV 308 SE in Healthy Subjects
CompletedNCT02223013
Start: 1999-04-30Updated: 2014-08-22
Relative Bioavailability and Tolerability of Various Experimental Formulations of BIBV 308 SE in Healthy Subjects
CompletedNCT02223000
Start: 1998-03-31Updated: 2014-08-22